LCBiot-KKWKMRRNQFWVKVQRG-OH

Ref. 3D-PP48296

Informations sur le produit

• Nom: LCBiot-KKWKMRRNQFWVKVQRG-OH

Description

Peptide LCBiot-KKWKMRRNQFWVKVQRG-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using LCBiot-KKWKMRRNQFWVKVQRG-OH include the following: Effector peptides from glutathione-S-transferase-pi affect the activation of jun by jun-N-terminal kinase V Adler, MR Pincus - Annals of Clinical & Laboratory Science, 2004 - Assoc Clin Scientistshttp://www.annclinlabsci.org/content/34/1/35.short NMR Solution Structure of a Peptide from the mdm-2 Binding Domain of the p53 Protein that Is Selectively Cytotoxic to Cancer Cells, R Rosal, MR Pincus, PW Brandt-Rauf, RL Fine - Biochemistry, 2004 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/bi035718g Designed novel nuclear localizing anticancer peptide targets p53 negative regulator MDM2 protein N Mukherjee , D Bhunia , PK Garai - Journal of Peptide , 2024 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/psc.3535 Development of new anti-cancer peptides from conformational energy analysis of the oncogenic ras-p21 protein and its complexes with target proteins MR Pincus - Front. Biosci, 2004 - article.imrpress.comhttps://article.imrpress.com/bri/Landmark/articles/pdf/Landmark1496.pdf Current Research in Biotechnology M Yang, S Liu, C Zhang - researchgate.nethttps://www.researchgate.net/profile/Chunye-Zhang/publication/369044042_Antimicrobial_peptides_with_antiviral_and_anticancer_properties_and_their_modification_and_nanodelivery_systems/links/647a8b8cb3dfd73b775dd43e/Antimicrobial-peptides-with-antiviral-and-anticancer-properties-and-their-modification-and-nanodelivery-systems.pdf Antimicrobial peptides with antiviral and anticancer properties and their modification and nanodelivery systems M Yang , S Liu, C Zhang - Current Research in Biotechnology, 2023 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S2590262823000035 Peptides designed from molecular modeling studies of the ras-p21 protein induce phenotypic reversion of a pancreatic carcinoma cell line but have no effect on M Kanovsky, J Michl, G Botzolaki, J Morin - Cancer chemotherapy , 2003 - Springerhttps://link.springer.com/article/10.1007/s00280-003-0639-3 Peptides from the amino terminal mdm-2-binding domain of p53, designed from conformational analysis, are selectively cytotoxic to transformed cells M Kanovsky, A Raffo, L Drew, R Rosal - Proceedings of the , 2001 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.211280698 The anti-cancer peptide, PNC-27, induces tumor cell necrosis of a poorly differentiated non-solid tissue human leukemia cell line that depends on expression of HDM K Davitt, BD Babcock, M Fenelus - Annals of Clinical & , 2014 - Assoc Clin Scientistshttp://www.annclinlabsci.org/content/44/3/241.short Ex vivo efficacy of anti-cancer drug PNC-27 in the treatment of patient-derived epithelial ovarian cancer E Sarafraz-Yazdi, C Gorelick - Annals of Clinical & , 2015 - Assoc Clin Scientistshttp://www.annclinlabsci.org/content/45/6/650.short Designed multifunctional peptides for intracellular targets D Juretic - Antibiotics, 2022 - mdpi.comhttps://www.mdpi.com/2079-6382/11/9/1196 Anti-cancer tumor cell necrosis of epithelial ovarian cancer cell lines depends on high expression of hdm-2 protein in their membranes A Thadi , EM Gleeson , M Khalili - Annals of Clinical & , 2020 - Assoc Clin Scientistshttp://www.annclinlabsci.org/content/50/5/611.short

• Marque: Biosynth